Results 201 to 210 of about 48,181 (245)

Systemic MyoAAV-saRNA delivery activates endogenous utrophin and rescues dystrophic pathology in mdx mice. [PDF]

open access: yesRegen Ther
Xiahou Z   +8 more
europepmc   +1 more source

Generation and characterization of a mouse model of Becker muscular dystrophy with a deletion of Dmd exons 52 to 55.

open access: yesDis Model Mech
Perillat LOM   +9 more
europepmc   +1 more source

Using muscle homing peptide CyPep10 to deliver phosphorodiamidate morpholino oligomers in the mdx mouse. [PDF]

open access: yesMol Ther Nucleic Acids
Schneider AE   +11 more
europepmc   +1 more source

Longitudinal Changes of Motor Function in Becker Muscular Dystrophy. [PDF]

open access: yesNeurol Genet
Bello L   +13 more
europepmc   +1 more source

Ubiquitination-targeted therapies improve BMD iPSC myogenic cell engraftment and dystrophin expression <i>in vivo</i>. [PDF]

open access: yesMol Ther Methods Clin Dev
Liu M   +6 more
europepmc   +1 more source

Interaction of dystrophin fragments with model membranes

open access: bronze, 1997
Christine DeWolf   +7 more
openalex   +1 more source

Dystrophin‐deficiency increases the susceptibility to doxorubicin‐induced cardiotoxicity

open access: gold, 2007
Shiwei Deng   +6 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy